These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 16625856

  • 21. [Atypical pituitary tumors].
    Krysiak R, Okopień B, Korzekwa M.
    Pol Merkur Lekarski; 2012 May; 32(191):323-8. PubMed ID: 22779341
    [Abstract] [Full Text] [Related]

  • 22. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
    Kwekkeboom DJ, de Jong FH, Lamberts SW.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
    [Abstract] [Full Text] [Related]

  • 23. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy.
    Losa M, Fortunato M, Molteni L, Peretti E, Mortini P.
    Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369
    [Abstract] [Full Text] [Related]

  • 24. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
    Blanco C, Lucas T, Alcañiz J, Davila N, Serrano P, Barcelò B, Estrada J.
    J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
    [Abstract] [Full Text] [Related]

  • 25. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
    Greenman Y, Tordjman K, Osher E, Veshchev I, Shenkerman G, Reider-Groswasser II, Segev Y, Ouaknine G, Stern N.
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):39-44. PubMed ID: 15963059
    [Abstract] [Full Text] [Related]

  • 26. Analysis of secretory, immunostaining and clinical characteristics of human "functionless" pituitary adenomas: transdifferentiation or gonadotropinomas?
    de Oliveira Machado AL, Adams EF, Schott W, Nomikos P, Fahlbusch R, Buchfelder M.
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):344-9. PubMed ID: 15977103
    [Abstract] [Full Text] [Related]

  • 27. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
    Roche C, Zamora AJ, Taïeb D, Lavaque E, Rasolonjanahary R, Dufour H, Bagnis C, Enjalbert A, Barlier A.
    J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
    [Abstract] [Full Text] [Related]

  • 28. Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.
    Chanson P, Lahlou N, Warnet A, Roger M, Sassolas G, Lubetzi J, Schaison G, Bouchard P.
    J Endocrinol Invest; 1994 Feb; 17(2):91-8. PubMed ID: 8006338
    [Abstract] [Full Text] [Related]

  • 29. [Clinically non functioning pituitary adenomas and gonadotroph-cell adenomas].
    Caron P.
    Presse Med; 2009 Jan; 38(1):103-6. PubMed ID: 18990542
    [Abstract] [Full Text] [Related]

  • 30. SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas.
    Fedele M, De Martino I, Pivonello R, Ciarmiello A, Del Basso De Caro ML, Visone R, Palmieri D, Pierantoni GM, Arra C, Schmid HA, Hofland L, Lombardi G, Colao A, Fusco A.
    Clin Cancer Res; 2007 May 01; 13(9):2738-44. PubMed ID: 17473207
    [Abstract] [Full Text] [Related]

  • 31. Non-functioning pituitary adenomas.
    Greenman Y, Stern N.
    Best Pract Res Clin Endocrinol Metab; 2009 Oct 01; 23(5):625-38. PubMed ID: 19945027
    [Abstract] [Full Text] [Related]

  • 32. Pediatric pituitary adenoma: a series of 42 patients.
    Pandey P, Ojha BK, Mahapatra AK.
    J Clin Neurosci; 2005 Feb 01; 12(2):124-7. PubMed ID: 15749410
    [Abstract] [Full Text] [Related]

  • 33. In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas.
    Andersen M, Bjerre P, Schrøder HD, Edal A, Høilund-Carlsen PF, Pedersen PH, Hagen C.
    Clin Endocrinol (Oxf); 2001 Jan 01; 54(1):23-30. PubMed ID: 11167922
    [Abstract] [Full Text] [Related]

  • 34. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M.
    Neuro Endocrinol Lett; 2009 Mar 01; 30(1):107-10. PubMed ID: 19300395
    [Abstract] [Full Text] [Related]

  • 35. Clinically non-functioning pituitary adenomas: Pathogenic, diagnostic and therapeutic aspects.
    Mercado M, Melgar V, Salame L, Cuenca D.
    Endocrinol Diabetes Nutr; 2017 Mar 01; 64(7):384-395. PubMed ID: 28745610
    [Abstract] [Full Text] [Related]

  • 36. Fetal gonadotrope cell origin of FSH-secreting pituitary adenoma - insight into human pituitary tumour pathogenesis.
    Davis JR, McNeilly JR, Norris AJ, Pope C, Wilding M, McDowell G, Holland JP, McNeilly AS.
    Clin Endocrinol (Oxf); 2006 Nov 01; 65(5):648-54. PubMed ID: 17054468
    [Abstract] [Full Text] [Related]

  • 37. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
    Fonseca AL, Chimelli L, Santos MJ, Santos AA, Violante AH.
    Arq Neuropsiquiatr; 2002 Sep 01; 60(3-A):590-602. PubMed ID: 12244397
    [Abstract] [Full Text] [Related]

  • 38. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
    Rishi A, Sharma MC, Sarkar C, Jain D, Singh M, Mahapatra AK, Mehta VS, Das TK.
    Neurol India; 2010 Sep 01; 58(3):418-23. PubMed ID: 20644271
    [Abstract] [Full Text] [Related]

  • 39. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
    Langsenlehner T, Stiegler C, Quehenberger F, Feigl GC, Jakse G, Mokry M, Langsenlehner U, Kapp KS, Mayer R.
    Strahlenther Onkol; 2007 May 01; 183(5):241-7. PubMed ID: 17497095
    [Abstract] [Full Text] [Related]

  • 40. Cabergoline modulation of alpha-subunits and FSH secretion in a gonadotroph adenoma.
    Giusti M, Bocca L, Florio T, Foppiani L, Corsaro A, Auriati L, Spaziante R, Schettini G, Giordano G.
    J Endocrinol Invest; 2000 May 01; 23(7):463-6. PubMed ID: 11005271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.